Logo (Nyvepria 01)
Nyvepria Injection, Solution
Product Images NDC 0069-0324
20 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Nyvepria (NDC 0069-0324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Nyvepria 02)
Figure (Nyvepria 03)
An instructional line drawing of a prefilled syringe displaying labeled components including the plunger rod, finger grip, label and expiration date, needle guard, syringe barrel, medicine, unactivated needle safety spring, and needle cover. This shows the parts of an injection syringe commonly used for subcutaneous administration.*
Figure (Nyvepria 04)
An instructional diagram illustrating the components of a used injectable device for NYVEPRIA (pegfilgrastim-apgf) 6 mg/0.6 mL injection solution. Labels identify the used plunger rod, extended needle guard, activated needle safety spring, and the needle cover off, highlighting safety features of the subcutaneous injection device.*
Figure (Nyvepria 04a)
An instructional diagram depicting a hand holding a prefilled syringe with a needle guard. The image shows the action to grab the needle guard, indicated by arrows pointing to the area to grip, illustrating part of the preparation or administration process for the injection.*
Figure (Nyvepria 05)
Illustration of a prefilled syringe for NYVEPRIA (pegfilgrastim-apgf) 6 mg/.6 mL subcutaneous injection. The diagram labels key parts including the needle cover, medicine reservoir, and the location for the label and expiration date on the syringe barrel.*
Figure (Nyvepria 06)
Illustration showing components for NYVEPRIA injection, including a prefilled syringe labeled with lot and expiration information, an alcohol wipe, a cotton ball, an adhesive bandage, and a sharps disposal container. These components are used together for subcutaneous administration of pegfilgrastim-apgf 6 mg/0.6 mL solution by Pfizer Laboratories.*
Figure (Nyvepria 07)
An instructional diagram showing preferred subcutaneous injection sites on a human body. The image highlights the upper arm, stomach area (abdomen), thigh, and buttocks as suitable locations for injection, with front and back views of the body outlined in black and gray shading over injection areas.*
Figure (Nyvepria 08)
An instructional line drawing showing a hand holding a cloth or wipe and cleaning the skin surface on the thigh area, likely illustrating preparation for a subcutaneous injection site.*
Figure (Nyvepria 09)
An instructional illustration showing the removal of the needle cap by pulling straight off an injection device, followed by disposing of the needle cap into a sharps disposal container. The images depict hand movements involved in these steps.*
Figure (Nyvepria 10)
An instructional black and white line drawing showing a hand pressing or applying gentle pressure to the upper thigh area, suggesting a subcutaneous injection site for medication administration.*
Figure (Nyvepria 11)
An instructional diagram illustrating the proper subcutaneous injection technique using a syringe and needle. It shows the syringe positioned at a 90-degree angle for injection and a 45-degree angle option, with a hand administering the injection to the skin above a bent knee.*
Figure (Nyvepria 12)
An instructional diagram showing a hand holding a syringe poised for subcutaneous injection into the skin of a person's upper thigh, indicated by a downward arrow. The illustration demonstrates the injection technique for a subcutaneous route.*
Figure (Nyvepria 13)
An instructional illustration showing hands administering a subcutaneous injection into a knee area using a prefilled syringe. The syringe is held upright and positioned for injection, with one hand stabilizing the skin.*
Figure (Nyvepria 14)
An instructional illustration showing a hand holding a syringe. The syringe has a visible coiled spring inside, and the diagram includes a close-up circle highlighting the needle in a retracted position after injection. The image demonstrates the safety mechanism of the needle retracting into the syringe barrel.*
Figure (Nyvepria 15)
An instructional illustration showing a hand disposing of a prefilled syringe into a sharps disposal container. The syringe is being inserted vertically into the container, indicating proper disposal after subcutaneous injection use.*
Figure (Nyvepria 16)
Principal Display Panel (6 mg/0.6 mL Syringe Label)
Label for Nyvepria (pegfilgrastim-apgf) injection, 6 mg/0.6 mL, a single-dose prefilled syringe with needle guard for subcutaneous use. Manufactured by Hospira, a Pfizer company, in Lake Forest, IL, USA. Includes NDC 0069-0324-01 and barcode, with production data and lot/expiration placeholders.*
Principal Display Panel (6 mg/0.6 mL Syringe Carton)
Packaging label for NYVEPRIA (pegfilgrastim-apgf) Injection, 6 mg/0.6 mL, a single-dose prefilled syringe with needle guard for subcutaneous use. The label shows Pfizer Oncology as the labeler, includes dosing and product information, and indicates no preservative in the sterile solution. The NDC is 0069-0324.*
Principal Display Panel (6 mg/0.6 mL Syringe Carton)
Packaging label for Nyvepria 6 mg/0.6 mL injection, a pegfilgrastim-apgf solution for subcutaneous use. The label indicates it is a sterile, preservative-free prefilled syringe with needle guard. Manufactured by Pfizer Laboratories Div Pfizer Inc, the package is designed for a single-dose 6 mg/0.6 mL syringe. The label includes product and manufacturer details, NDC 0069-0324-01, and usage instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
